Big Gain For Evoke Pharma, Inc.
Thu, Dec 09, 2021 at 05:30 PM
Evoke Pharma, Inc. (EVOK:NASDAQ) soared at $0.76, a gain of 26.6%. On Wed, Dec 08, 2021, EVOK:NASDAQ touched a New 2-Week Intraday Low of $0.55. The stock appeared on our News Catalysts scanner on Wed, Nov 10, 2021 at 06:02 PM in the 'EARNINGS' category. From Wed, Nov 24, 2021, the stock recorded 33.33% Up Days and 30.00% Green Days
The stock spiked on Fri, Aug 13, 2021 at $1.58 with a volume of 1B+.
About Evoke Pharma, Inc. (EVOK:NASDAQ)
Evoke Pharma Inc is a specialty pharmaceutical company which focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. It is engaged in developing an investigational metoclopramide nasal spray called Gimoti.
Top 10 Gainers:
- IINN (IINN:NASDAQ), 84.01%
- American Virtual Cloud Technologies, Inc. (AVCT:NASDAQ), 82.52%
- ENSC (ENSC:NASDAQ), 66.78%
- Evoke Pharma, Inc. (EVOK:NASDAQ), 26.61%
- China Online Education Group (COE:NYSE), 24.6%
- Insignia Systems, Inc. (ISIG:NASDAQ), 22.97%
- HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ), 20.94%
- HUDI (HUDI:NASDAQ), 20.17%
- BZ (BZ:NASDAQ), 19.12%
- JSPR (JSPR:NASDAQ), 17.81%